Company Description
DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand.
Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.
The company offers Dario Connect, a solution used to create communities around specific health conditions to increase awareness and education; Dario Mind, a behavioral health offering that decreases the symptoms of stress, anxiety, and depression; Dario Move, focuses on improving posture to alleviate pain with medical device; and Dario Health, a self-care application and virtual coaching platform for diabetes, hypertension, and weight management and GLP-1.
It also provides bundled full-suite or partial-suite subscriptions. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016.
DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.
| Country | United States |
| Founded | 2011 |
| Industry | Health Information Services |
| Sector | Healthcare |
| Employees | 202 |
| CEO | Erez Raphael |
Contact Details
Address: 322 W 57th Street, suite 33 B New York, New York 10019 United States | |
| Website | dariohealth.com |
Stock Details
| Ticker Symbol | DRIO |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001533998 |
| CUSIP Number | 23725P209 |
| ISIN Number | US23725P2092 |
| Employer ID | 45-2973162 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Erez Raphael | Chief Executive Officer and Director |
| Steven C. Nelson | President and Chief Commercial Officer |
| Dov Oppenheim | Co-Founder and Production Chief |
| Chen Franco-Yehuda | Chief Financial Officer, Treasurer and Secretary |
| Lara Dodo | Chief Operations Officer |
| Kat Parrella | Investor Relations Manager |
| Mona Dean | Chief Compliance Officer |
| Claudia Levi | Content and Communications Manager |
| Michal Aberman-Shimon | Chief People Officer |
| Dr. Omar Manejwala M.D. | Chief Medical Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 12, 2025 | 10-Q | Quarterly Report |
| Aug 7, 2025 | EFFECT | Notice of Effectiveness |
| Jul 31, 2025 | S-3 | Registration statement under Securities Act of 1933 |
| Jul 23, 2025 | 8-K | Current Report |
| Jul 22, 2025 | SCHEDULE 13G | Filing |
| Jul 18, 2025 | SCHEDULE 13G/A | Filing |
| Jul 10, 2025 | 8-K | Current Report |
| Jun 5, 2025 | EFFECT | Notice of Effectiveness |
| Jun 2, 2025 | UPLOAD | Filing |
| Jun 2, 2025 | SD | Form - SD |